There is a need in the medical profession for an apparatus and method capable of monitoring and transmitting physiological and wellness parameters of ambulatory patients to a remote site where a medical professional caregiver evaluates such physiological and wellness parameters. Specifically, there is a need for an interactive apparatus that is coupled to a remote computer such that a medical professional caregiver can supervise and provide medical treatment to remotely located ambulatory patients.
There is needed an apparatus that monitors and transmits physiological and wellness parameters of ambulatory patients to a remote computer, whereby a medical professional caregiver evaluates the information and provokes better overall health care and treatment for the patient. Accordingly, such an apparatus can be used to prevent unnecessary hospitalizations of such ambulatory patients.
Also, there is needed an apparatus for monitoring and transmitting such physiological and wellness parameters that is easy to use and that is integrated into a single unit. For example, there is a need for an ambulatory patient monitoring apparatus that comprises: a transducing device for providing electronic signals representative of measured physiological parameters, such as weight; an input/output device; and a communication device as a single integrated unit that offers ambulatory patients ease of use, convenience and portability.
Patients suffering from chronic diseases, such as chronic heart failure, will benefit from such home monitoring apparatus. These patients normally undergo drug therapy and lifestyle changes to manage their medical condition. In these patients, the medical professional caregiver monitors certain wellness parameters and symptoms including: weakness, fatigue, weight gain, edema, dyspnea (difficulty breathing or shortness of breath), nocturnal cough, orthopnea (inability to lie flat in bed because of shortness of breath), and paroxysmal nocturnal dyspnea (awakening short of breath relieved by sitting or standing); and body weight to measure the response of drug therapy. Patients will also benefit from daily reminders to take medications (improving compliance), reduce sodium intake and perform some type of exercise. With the information received from the monitoring device, the medical professional caregiver can determine the effectiveness of the drug therapy, the patient's condition, whether the patient's condition is improving or whether the patient requires hospitalization or an office consultation to prevent the condition from getting worse.
Accordingly, there is needed an apparatus and method for monitoring the patients from a remote location, thus allowing medical professional caregivers to receive feedback of the patient's condition without having to wait until the patient's next office visit. In addition, there is needed an apparatus and method that allows medical professional caregivers to monitor and manage the patient's condition to prevent the rehospitalization of such patient, or prevent the patient's condition from deteriorating to the point where hospitalization would be required. As such, there are social as well as economic benefits to such an apparatus and method.
The patient receives the benefits of improved health when the professional caregiver is able to monitor and quickly react to any adverse medical conditions of the patient or to any improper responses to medication. Also, society benefits because hospital resources will not be utilized unnecessarily.
As a group, patients suffering from chronic heart failure are the most costly to treat. There are approximately 5 million patients in the U.S.A. and 15 million worldwide with chronic heart failure. The mortality rate of patients over 65 years of age is 50%. Of those that seek medical help and are hospitalized, 50% are rehospitalized within 6 months. Of these, 16% will be rehospitalized twice. The patients that are hospitalized spend an average of 9.1 days in the hospital at a cost of $12,000.00 for the period. Accordingly, there is a need to reduce the rehospitalization rate of chronic heart failure patients by providing improved in-home patient monitoring, such as frequently monitoring the patient's body weight and adjusting the drug therapy accordingly.
Approximately 60 million American adults ages 20 through 74 are overweight. Obesity is a known risk factor for heart disease, high blood pressure, diabetes, gallbladder disease, arthritis, breathing problems, and some forms of cancer such as breast and colon cancer. Americans spend $33 billion dollars annually on weight-reduction products and services, including diet foods, products and programs.
There is a need in the weight management profession for an apparatus and method capable of monitoring and transmitting physiological and wellness parameters of overweight/obese patients to a remote site where a weight management professional or nutritionist evaluates such physiological and wellness parameters. Specifically, there is a need for an interactive apparatus that is coupled to a remote computer such that a weight management professional or nutritionist can supervise and provide nutritional guidance to remotely located individuals.
The apparatus allows overweight individuals to participate in a weight loss/management program with accurate weight monitoring from home. The apparatus improves the convenience for the individual participant by eliminating the need to constantly commute to the weight management center and “weigh-in.” Furthermore, the individual can participate in a weight management program while under professional supervision from the privacy and comfort of their own home. Moreover, the apparatus allows the weight management professional to intervene and adapt the individuals diet and exercise routine based on the weight and wellness information received.
For the foregoing reasons, there is a need for an apparatus, system and method capable of monitoring and transmitting physiological and wellness parameters of ambulatory patients, such as body weight, to a remote location where a medical professional caregiver, weight management professional or nutritionist can evaluate and respond to the patient's medical wellness condition.
The invention is directed to an apparatus, system and method that satisfies this need. The apparatus having features of the invention is capable of monitoring an ambulatory patient and establishing two way communication to a medical professional caregiver, weight management professional or nutritionist regarding the wellness parameters of such an ambulatory patient.
The apparatus comprises a physiological parameter transducing device. The device generates an electronic signal that is representative of the value of the physiological parameter being monitored. The apparatus further comprises a central processor device. The central processor device is operatively coupled to the parameter transducing device and processes the electronic signals that are representative of the physiological parameters. The apparatus further comprises an electronic receiver/transmitter communication device. The communication device having one end operatively coupled to the processor and another end operatively coupled to a communication network. The communication device is activated whenever the central processor recognizes a physiological parameter within a predetermined range. The apparatus further comprises an input device. The input device is operatively coupled to said processor and configured to receive external commands. The apparatus further comprises an output device. The output device is coupled to the processor and provides information comprising external commands, physiological symptoms, wellness parameters, and queries from the communication device. All of these devices are integrated into a single unit.
The system having features of the invention monitors an ambulatory patient and establishes communication to a caregiver, regarding the wellness parameters of such an ambulatory patient, between a first location and a remote central office location. The system comprises a monitoring apparatus located at the first location. The monitoring apparatus comprises: (a) a physiological parameter transducing device that generates an electronic signal representative of the value of the physiological parameter being monitored; (b) a central processor device that is operatively coupled to the parameter transducing device for processing the physiological parameter electronic signals; (c) an electronic receiver/transmitter communication device, said communication device having one end operatively coupled to the processor and another end operatively coupled to a communication network that is activated whenever the central processor recognizes a physiological parameter within a predetermined range; (d) an input device that is operatively coupled to the processor and configured to receive external commands; (e) an output device coupled to the processor that provides information comprising external commands, physiological symptoms, wellness parameters, and queries from the communication device, wherein these devices are integrated into a single unit. The system further comprises a processing computer at a remote central office location that is in communication with the remote monitoring apparatus and exchanges information with the monitoring apparatus.
The method having features of the invention monitors an ambulatory patient and establishes communication to a caregiver regarding the wellness parameters of such an ambulatory patient. The method comprises monitoring a physiological parameter; generating an electronic signal representative of the value of the physiological parameter; in a central processor device, processing the physiological parameter electronic signals; communicating the processed electronic signals between a first location and a remote central location; inputting external commands into the processor; and outputting the information.
These and other features, aspects and advantages of the invention will become better understood with regard to the following description, appended claims and accompanying drawings where:
The embodiments of the invention described herein are implemented as a medical apparatus, system and method capable of monitoring wellness parameters and physiological data of ambulatory patients and transmitting such parameters and data to a remote location. At the remote location a medical professional caregiver monitors the patient's condition and provides medical treatment as may be necessary.
The monitoring device incorporates transducing devices for converting the desired measured parameters into electrical signals capable of being processed by a local computer or microprocessor system. The device interacts with the ambulatory patient and then, via an electronic communication device such as a modem, transmits the measured parameters to a computer located at a remote site. At the remote location the various indicia of the ambulatory patient's condition are monitored and analyzed by the medical professional caregiver. To provide the ambulatory patient with an added level of convenience and ease of use, such monitoring device is contained in a single integrated package.
Communication is established between the monitoring apparatus and a remote computer via modem and other electronic communication devices that are generally well known commercially available products. At the remote location, the caregiver reviews the patient's condition based on the information communicated (e.g. wellness parameters and physiological data) and provokes medical treatment in accordance with such information.
Referring now to
It will be appreciated that other physiological transducing devices can be utilized in addition to the electronic scale 18. For example, blood pressure measurement apparatus and electrocardiogram (EKG) measurement apparatus can be utilized with the integrated monitoring apparatus 10 for recordation and/or transmission of blood pressure and EKG measurements to a remote location. It will be appreciated that other monitoring devices of physiological body functions that provide an analog or digital electronic output may be utilized with the monitoring apparatus 10.
Referring to
Furthermore,
Referring now to
It will be appreciated by those skilled in the art that the monitoring apparatus requires an electrical power source 19 to operate. As such, the monitoring apparatus may be powered by: ordinary household A/C line power, DC batteries or rechargeable batteries. Power source 19 provides electrical power to the housing for operating the electronic devices. A power source for operating the electronic scale 18 is generated within the housing, however those skilled in the art will recognize that a separate power supply may be provided or the power source 19 may be adapted to provide the proper voltage or current for operating the electronic scale 18.
The housing 14 includes a microprocessor system 24, an electronic receiver/transmitter communication device such as a modem 36, an input device 28 and an output device 30. The modem 36 is operatively coupled to the microprocessor system 24 via the electronic bus 46, and to a remote computer 32 via a communication network 34 and modem 35. The communication network 34 being any communication network such as the telephone network, wide area network or Internet. It will be appreciated that the modem 36 is a generally well known commercially available product available in a variety of configurations operating at a variety of BAUD rates. In one embodiment of the invention the modem 36 is asynchronous, operates at 2400 BAUD and is readily available off-the-shelf from companies such as Rockwell or Silicon Systems Inc. (SSI).
It will be appreciated that output device(s) 30 may be interfaced with the microprocessor system 24. These output devices 30 include a visual electronic display device 31 and/or a synthetic speech device 33. Electronic display devices 31 are well known in the art and are available in a variety of technologies such as vacuum fluorescent, liquid crystal or Light Emitting Diode (LED). The patient reads alphanumeric data as it scrolls on the electronic display device 31. Output devices 30 include a synthetic speech output device 33 such as a Chipcorder manufactured by ISD (part No. 4003). Still, other output devices include pacemaker data input devices, drug infusion pumps or transformer coupled transmitters.
It will be appreciated that input device(s) 28 may be interfaced with the microprocessor system 24. In one embodiment of the invention an electronic keypad 29 is provided for the patient to enter responses into the monitoring apparatus. Patient data entered through the electronic keypad 29 may be scrolled on the electronic display 31 or played back on the synthetic speech device 33.
The microprocessor system 24 is operatively coupled to the modem 36, the input device(s) 28 and the output device(s) 30. The electronic scale 18 is operatively coupled to the central system 24. Electronic measurement signals from the electronic scale 18 are processed by the A/D converter 15. This digitized representation of the measured signal is then interfaced to the CPU 38 via the electronic bus 46 and the bus controller 44. In one embodiment of the invention, the physiological transducing device includes the electronic scale 18. The electronic scale 18 is generally well known and commercially available. The electronic scale 18 may include one or more of the following elements: load cells, pressure transducers, linear variable differential transformers (LVDTs), capacitance coupled sensors, strain gages and semiconductor strain gages. These devices convert the patient's weight into a useable electronic signal that is representative of the patient's weight.
In will be appreciated that Analog-to-Digital (A/D) converters are also generally well known and commercially available in a variety of configurations. Furthermore, an A/D converter 15 may be included within the physiological transducing device or within the microprocessor system 24 or within the housing 14. One skilled in the art would have a variety of design choices in interfacing a transducing device comprising an electronic sensor or transducer with the microprocessor system 24.
The scale 18 may provide an analog or digital electronic signal output depending on the particular type chosen. If the electronic scale 18 provides an analog output signal in response to a weight input, the analog signal is converted to a digital signal via the A/D converter 15. The digital signal is then interfaced with the electronic bus 46 and the CPU 38. If the electronic scale 18 provides a digital output signal in response to a weight input, the digital signal may be interfaced with electronic bus 46 and the CPU 38.
In one embodiment of the invention, such transceivers operate at radio frequencies in the range of 900-2400 MHz. Information from the microprocessor system 24 is encoded and modulated by the first RF device 50 for subsequent transmission to the second RF device 54, located remotely therefrom. The second RF device 54 is coupled to a conventional modem 58 via the microprocessor 55. The modem 58 is coupled to the communication network 34 via a in-house wiring connection and ultimately to the modem 35 coupled to the remote computer 32. Accordingly, information may be transmitted to and from the microprocessor system 24 via the RF devices 50, 54 via a radio wave or radio frequency link, thus providing added portability and flexibility to the monitoring apparatus 10. It will be appreciated that various other communications devices may be utilized such as RS-232 serial communication connections, Internet communications connection as well as satellite communication connections. Other communications devices that operate by transmitting and receiving infra-red (IR) energy can be utilized to provide a wireless communication link between the patient monitoring apparatus 10 and a conveniently located network connection. Furthermore, X-10™ type devices can also be used as part of a communication link between the patient monitoring apparatus 10 and a convenient network connection in the home. X-10 USA and other companies manufacture a variety of devices that transmit/receive data without the need for any special wiring. The devices works by sending signals through the home's regular electrical wires using what is called power line carrier (PLC).
Referring now to
Referring now to
Operations to perform the preferred embodiment of the invention are shown in
Block 66 illustrates the operation of converting a monitored or measured physiological parameter from a mechanical input to an electronic output by utilizing a transducing device. In one embodiment of the invention the transducing device is an electronic scale 18, which converts the patient's weight into a useable electronic signal.
At block 68, the microprocessor system 24 processes the electronic signal representative of the transduced physiological parameter. If the resulting parameter value is within certain preprogrammed limits the microprocessor system 24 initiates communication within the remote computer 32 via the communication device 36 over the communication network 34.
Block 70 illustrates the operation whereby information such as wellness parameters and physiological data are communicated between the monitoring apparatus 10 and the ambulatory patient. An exemplary list of the questions asked to the patient by the monitoring apparatus are provided in Table 5.
Referring now to
The load cell 100 is a transducer that responds to a forces applied to it. During operation, when a patient steps on the electronic scale 18, the load cell 100 responds to a force “F” transmitted through the top plate 11 and a first support/mounting surface 96. The support/mounting surface 96 is contact with a first end on a top side of the load cell 100. A force “F′” that is equal and opposite to “F” is transmitted from the surface that the electronic scale 18 is resting on, thorough the base plate 12 and a second support/mounting surface 98. The second support/mounting surface 98 is in contact with a second end on a bottom side of the load cell 100. In one embodiment, the load cell 100 is attached to the top plate 11 and the base plate 12, respectively, with bolts that engage threaded holes provided in the load cell 100. In one embodiment the load cell 100 further comprises a strain gage 102.
The strain gage 102 made from ultra-thin heat-treated metallic foils. The strain gage 102 changes electrical resistance when it is stressed, e.g. placed in tension or compression. The strain gage 102 is mounted or cemented to the load cell 100 using generally known techniques in the art, for example with specially formulated adhesives, urethanes, epoxies or rubber latex. The positioning of the strain gage 102 will generally have some measurable effect on overall performance of the load cell 100. Furthermore, it will be appreciated by those skilled in the art that additional reference strain gages may be disposed on the load cell where they will not be subjected to stresses or loads for purposes of temperature compensating the strain gage 102 under load. During operation over varying ambient temperatures, signals from the reference strain gages may be added or subtracted to the measurement signal of the strain gage 102 under load to compensate for any adverse effects of ambient temperature on the accuracy of the strain gage 102.
The forces, “F” and “F′”, apply stress to the surface on which the strain gage 102 is attached. The weight of the patient applies a load on the top plate 11. Under the load the strain gage(s) 102 mounted to the top of the load cell 100 will be in tension/compression as the load cell bends. As the strain gage 102 is stretched or compressed its resistance changes proportionally to the applied load. The strain gage 102 is electrically connected such that when an input voltage or current is applied to the strain gage 102, an output current or voltage signal is generated which is proportional to the force applied to the load cell 100. This output signal is then converted to a digital signal by A/D converter 15.
The design of the load cell 100 having a first end on a top side attached to the top plate 11 and a second end on a bottom side attached to the base plate 12 provides a structure for stressing the strain gage 102 in a repeatable manner. The structure enables a more accurate and repeatable weight measurement. This weight measurement is repeatable whether the scale 18 rests on a rigid tile floor or on a carpeted floor.
Table 1 shows multiple comparative weight measurements taken with the electronic scale 18 resting on a tile floor and a carpeted floor without rubber feet on the scale 18. The measurements were taken using the same load cell 100. The thickness “T” of the top plate 11 and supporting ribs was 0.125″ except around the load cell, where the thickness of the supporting ribs was 0.250″. The thickness of the load cell 100 support/mounting surfaces 96, 98 (
Table 2 shows multiple weight measurements taken with the scale 18 on a tile floor and a carpeted floor with rubber feet on the bottom of the scale 18. The measurements were taken using the same load cell 100. The thickness “T” of the top plate 11 was 0.125″ including the thickness around the load cell. As indicated in Table 2, with the scale 18 resting on a tile floor on rubber feet, the average measured weight was 146.62 lbs., with a standard deviation of 0.07888. Subsequently, with the scale 18 resting on a 0.5″ carpet with 0.38″ pad underneath and an additional 0.5″ rug on top of the carpet, the average measured weight was 146.62 lbs., with a standard deviation of 0.04216.
Table 3 shows multiple weight measurements taken with an off-the-shelf conventional electronic scale. As indicated in table 3, with the off-the-shelf conventional scale resting on the tile floor, the average measured weight was 165.5571 lbs., with a standard deviation of 0.20702. Subsequently, with the off-the-shelf conventional scale resting on a 0.5″ carpet with 0.38″ pad underneath and an additional 0.5″ rug on top of the carpet, the average measured weight was 163.5143 lbs., with a standard deviation of 0.13093.
The summary in Table 4 is a comparative illustration of the relative repeatability of each scale while resting either on a tile floor or on a carpeted floor.
The foregoing description was intended to provide a general description of the overall structure of several embodiments of the invention, along with a brief discussion of the specific components of these embodiments of the invention. In operating the apparatus 10, an ambulatory patient utilizes the monitoring apparatus 10 to obtain a measurement of a particular physiological parameter. For example, an ambulatory patient suffering from chronic heart failure will generally be required to monitor his or her weight as part of in-home patient managing system. Accordingly, the patient measures his or her weight by stepping onto the electronic scale 18, integrally located within the base plate 12 of the monitoring apparatus 10.
Referring now to
Upon measuring the weight, the microprocessor system 24 determines whether it is within a defined, required range such as +/−10 lbs. or +/−10% of a previously recorded weight stored in memory 40. The monitoring apparatus 10 then initiates a call via the modem 36 to the remote site 62. Communications is established between the local monitoring apparatus 10 and the remote computer 32. In one embodiment of the invention, the patient's weight is electronically transferred from the monitoring apparatus 10 at the local site 58 to the remote computer 32 at the remote site 62. At the remote site 62 the computer program compares the patient's weight with the dry weight and wellness information and updates various user screens. The program can also analyze the patient's weight trend over the previous 1-21 days. If significant symptoms and/or excessive weight changes are reported, the system alerts the medical care provider who may provoke a change to the patient's medication dosage, or establish further communication with the patient such as placing a telephone to the patient. The communication between the patient's location and the remote location may be one way or two way communication depending on the particular situation.
To establish the patient's overall condition, the patient is prompted via the output device(s) 30 to answer questions regarding various wellness parameters. An exemplary list of questions, symptoms monitored and the related numerical score is provided in Table 5 as follows:
At the remote site 62 the medical professional caregiver evaluates the overall score according to the wellness parameter interrogation responses (as shown in Table 5). For example, if the patient's total score is equal to or greater than 10, an exception is issued and will either prompt an intervention by the medical professional caregiver in administering medication, or prompt taking further action in the medical care of the patient.
The output device(s) 30 varies based on the embodiment of the invention. For example, the output device may be a synthetic speech generator 33. As such, the wellness parameters are communicated to the patient via the electronic synthetic speech generator 33 in the form of audible speech. It will be appreciated that electronic speech synthesizers are generally well known and widely available. The speech synthesizer converts electronic data to an understandable audible speech.
Accordingly, the patient responds by entering either “YES” or “NO” responses into the input device 28, which may include for example, an electronic keypad 29. However, in one embodiment of the invention, the input device may also include a generic speech recognition device such as those made by International Business Machines (IBM), Dragon Systems, Inc. and other providers. Accordingly, the patient replies to the interrogations merely by speaking either “YES” or “NO” responses into the speech recognition input device.
In embodiments of the invention that include electronic display 31 as an output device 30, the interrogations as well as the responses are displayed and/or scrolled across the display for the patient to read. Generally, the electronic display will be positioned such that it is viewable by the patient during the information exchanging process between the patient and the remote computer 32.
Upon uploading the information to the remote computer 32, the medical professional caregiver may telephone the patient to discuss, clarify or validate any particular wellness parameter or physiological data point. Furthermore, the medical professional caregiver may update the list of wellness parameter questions listed in Table 5 from the remote site 62 over the two way communication network 34. Modifications are transmitted from the remote computer 32 via modem 35, over the communication network 34, through modem 36 and to the monitoring apparatus 10. The modified query list is then stored in the memory 40 of the microprocessor system 24.
Thus, it will be appreciated that the previously described versions of invention provide many advantages, including addressing the needs in the medical profession for an apparatus and method capable of monitoring and transmitting physiological and wellness parameters of ambulatory patients to a remote site whereby a medical professional caregiver can evaluate such physiological and wellness parameters and make decisions regarding the patient's treatment.
Also, it will be appreciated that the previously described versions of invention provide other advantages, including addressing the need for an apparatus for monitoring and transmitting such physiological and wellness parameters that is available in an easy to use portable integrated single unit.
Also, it will be appreciated that the previously described versions of the invention provide still other advantages, including addressing the need for medical professional caregivers to monitor and manage the patient's condition to prevent the rehospitalization of the patient, and to prevent the patient's condition from deteriorating to the point where hospitalization may be required.
Although the invention has been described in considerable detail with reference to certain preferred versions thereof, other versions are possible. For example a weight management and control apparatus.
Therefore, the spirit and scope of the appended claims should not be limited to the description of the preferred versions contained herein.
This application is continuation of U.S. application Ser. No. 09/918,247, filed on Jul. 30, 2001, now U.S. Pat. No. 6,723,045 which is a divisional of U.S. application Ser. No. 09/293,619, filed Apr. 16, 1999, now U.S. Pat. No. 6,290,646 issued on Sep. 18, 2001, which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3743040 | Hutchinson et al. | Jul 1973 | A |
3907503 | Betts et al. | Sep 1975 | A |
3925762 | Heitlinger et al. | Dec 1975 | A |
4144306 | Figueras | Mar 1979 | A |
4328396 | Theis | May 1982 | A |
4476149 | Poppe et al. | Oct 1984 | A |
4510383 | Ruppender | Apr 1985 | A |
4531527 | Reinhold, Jr. et al. | Jul 1985 | A |
4535782 | Zoltan | Aug 1985 | A |
4556866 | Gorecki | Dec 1985 | A |
4576244 | Zeigner et al. | Mar 1986 | A |
4592893 | Poppe et al. | Jun 1986 | A |
RE32361 | Duggan | Feb 1987 | E |
4712562 | Ohayon et al. | Dec 1987 | A |
4724521 | Carron et al. | Feb 1988 | A |
4803625 | Fu et al. | Feb 1989 | A |
4835372 | Gombrich et al. | May 1989 | A |
4838275 | Lee | Jun 1989 | A |
4844187 | Jabero | Jul 1989 | A |
4877580 | Aronowitz et al. | Oct 1989 | A |
4899758 | Finkelstein et al. | Feb 1990 | A |
4916441 | Gombrich | Apr 1990 | A |
4935346 | Phillips et al. | Jun 1990 | A |
4947858 | Smith | Aug 1990 | A |
4998534 | Claxton et al. | Mar 1991 | A |
5012411 | Policastro et al. | Apr 1991 | A |
5019974 | Beckers | May 1991 | A |
5054493 | Cohn et al. | Oct 1991 | A |
5092330 | Duggan | Mar 1992 | A |
5113869 | Nappholz et al. | May 1992 | A |
5212546 | Arazi et al. | May 1993 | A |
5241966 | Finkelstein et al. | Sep 1993 | A |
5265010 | Evans-Paganelli et al. | Nov 1993 | A |
5265605 | Afflerbach | Nov 1993 | A |
5281395 | Markart et al. | Jan 1994 | A |
5307263 | Brown | Apr 1994 | A |
5331549 | Crawford, Jr. | Jul 1994 | A |
5339821 | Fujimoto | Aug 1994 | A |
5341291 | Roizen et al. | Aug 1994 | A |
5367667 | Wahlquist et al. | Nov 1994 | A |
5379057 | Clough et al. | Jan 1995 | A |
5390238 | Kirk et al. | Feb 1995 | A |
5402794 | Wahlstrand et al. | Apr 1995 | A |
5406955 | Bledsoe et al. | Apr 1995 | A |
5434611 | Tamura | Jul 1995 | A |
5437285 | Verrier et al. | Aug 1995 | A |
5441047 | David et al. | Aug 1995 | A |
5465082 | Chaco | Nov 1995 | A |
5467773 | Bergelson et al. | Nov 1995 | A |
5471382 | Tallman et al. | Nov 1995 | A |
5486999 | Mebane | Jan 1996 | A |
5515170 | Matzinger et al. | May 1996 | A |
5522396 | Langer et al. | Jun 1996 | A |
5549117 | Tacklind et al. | Aug 1996 | A |
5549654 | Powell | Aug 1996 | A |
5553609 | Chen et al. | Sep 1996 | A |
5553623 | Ochs | Sep 1996 | A |
5558638 | Evers et al. | Sep 1996 | A |
5560370 | Verrier et al. | Oct 1996 | A |
5563031 | Yu | Oct 1996 | A |
5573551 | Lin et al. | Nov 1996 | A |
5583758 | McIlroy et al. | Dec 1996 | A |
5584868 | Salo et al. | Dec 1996 | A |
5586557 | Nelson et al. | Dec 1996 | A |
5590648 | Mitchell et al. | Jan 1997 | A |
5594638 | Iliff | Jan 1997 | A |
5619991 | Sloane | Apr 1997 | A |
5622178 | Gilham | Apr 1997 | A |
5623656 | Lyons | Apr 1997 | A |
5633910 | Cohen | May 1997 | A |
5635060 | Hagen et al. | Jun 1997 | A |
5642731 | Kehr | Jul 1997 | A |
5660176 | Iliff | Aug 1997 | A |
5673691 | Abrams et al. | Oct 1997 | A |
5684826 | Ratner | Nov 1997 | A |
5687717 | Halpern et al. | Nov 1997 | A |
5704029 | Wright, Jr. | Dec 1997 | A |
5704364 | Saltzstein et al. | Jan 1998 | A |
5704366 | Tacklind et al. | Jan 1998 | A |
5711297 | Iliff | Jan 1998 | A |
5724032 | Klein et al. | Mar 1998 | A |
5724968 | Iliff | Mar 1998 | A |
5725559 | Alt et al. | Mar 1998 | A |
5743267 | Nikolic et al. | Apr 1998 | A |
5745555 | Mark | Apr 1998 | A |
5758652 | Nikolic | Jun 1998 | A |
5771511 | Kummer et al. | Jun 1998 | A |
5778882 | Raymond et al. | Jul 1998 | A |
5781442 | Engleson et al. | Jul 1998 | A |
5822715 | Worthington et al. | Oct 1998 | A |
5827180 | Goodman | Oct 1998 | A |
5828943 | Brown | Oct 1998 | A |
5832448 | Brown | Nov 1998 | A |
5839438 | Graettinger et al. | Nov 1998 | A |
5842997 | Verrier et al. | Dec 1998 | A |
5843139 | Goedeke et al. | Dec 1998 | A |
5846223 | Swartz et al. | Dec 1998 | A |
5868669 | Iliff | Feb 1999 | A |
5874988 | Gu | Feb 1999 | A |
5876353 | Riff | Mar 1999 | A |
5879163 | Brown et al. | Mar 1999 | A |
5890128 | Diaz et al. | Mar 1999 | A |
5897493 | Brown | Apr 1999 | A |
5899855 | Brown | May 1999 | A |
5910107 | Iliff | Jun 1999 | A |
5911687 | Sato et al. | Jun 1999 | A |
5913310 | Brown | Jun 1999 | A |
5918603 | Brown | Jul 1999 | A |
5931791 | Saltzstein et al. | Aug 1999 | A |
5933136 | Brown | Aug 1999 | A |
5935060 | Iliff | Aug 1999 | A |
5951300 | Brown | Sep 1999 | A |
5956683 | Jacobs et al. | Sep 1999 | A |
5957861 | Combs et al. | Sep 1999 | A |
5960403 | Brown | Sep 1999 | A |
5964700 | Tallman et al. | Oct 1999 | A |
5967979 | Taylor et al. | Oct 1999 | A |
5985559 | Brown | Nov 1999 | A |
5987519 | Peifer et al. | Nov 1999 | A |
5989917 | McAleer et al. | Nov 1999 | A |
5997476 | Brown | Dec 1999 | A |
6007493 | Ericksen et al. | Dec 1999 | A |
6014626 | Cohen | Jan 2000 | A |
6022315 | Iliff | Feb 2000 | A |
6024699 | Surwit et al. | Feb 2000 | A |
6032119 | Brown et al. | Feb 2000 | A |
6038465 | Melton, Jr. | Mar 2000 | A |
6045513 | Stone et al. | Apr 2000 | A |
6059724 | Campell et al. | May 2000 | A |
6063028 | Luciano | May 2000 | A |
6071236 | Iliff | Jun 2000 | A |
6080106 | Lloyd et al. | Jun 2000 | A |
6085162 | Cherny | Jul 2000 | A |
6088429 | Garcia | Jul 2000 | A |
6101478 | Brown | Aug 2000 | A |
6112224 | Peifer et al. | Aug 2000 | A |
6113540 | Iliff | Sep 2000 | A |
6117073 | Jones et al. | Sep 2000 | A |
6120440 | Goknar | Sep 2000 | A |
6126596 | Freedman | Oct 2000 | A |
6144837 | Quy | Nov 2000 | A |
6148233 | Owen et al. | Nov 2000 | A |
6151581 | Kraftson et al. | Nov 2000 | A |
6167362 | Brown et al. | Dec 2000 | A |
6168563 | Brown | Jan 2001 | B1 |
6168957 | Matzinger et al. | Jan 2001 | B1 |
6171237 | Avitall et al. | Jan 2001 | B1 |
6177940 | Bond et al. | Jan 2001 | B1 |
6217744 | Crosby | Apr 2001 | B1 |
6234964 | Iliff | May 2001 | B1 |
6240393 | Brown | May 2001 | B1 |
6246992 | Brown | Jun 2001 | B1 |
6248065 | Brown | Jun 2001 | B1 |
6269339 | Silver | Jul 2001 | B1 |
6270456 | Iliff | Aug 2001 | B1 |
6277071 | Hennessy et al. | Aug 2001 | B1 |
6283923 | Finkelstein et al. | Sep 2001 | B1 |
6290646 | Cosentino et al. | Sep 2001 | B1 |
6295506 | Heinonen et al. | Sep 2001 | B1 |
6328699 | Eigler et al. | Dec 2001 | B1 |
6336900 | Alleckson et al. | Jan 2002 | B1 |
6354996 | Drinan et al. | Mar 2002 | B1 |
6368273 | Brown | Apr 2002 | B1 |
6398727 | Bui et al. | Jun 2002 | B1 |
6402691 | Peddicord et al. | Jun 2002 | B1 |
6413213 | Essenpreis et al. | Jul 2002 | B1 |
6416471 | Kumar et al. | Jul 2002 | B1 |
6454705 | Cosentino et al. | Sep 2002 | B1 |
6473638 | Ferek-Petric | Oct 2002 | B2 |
6477424 | Thompson et al. | Nov 2002 | B1 |
6493568 | Bell et al. | Dec 2002 | B1 |
6541266 | Modzelewski et al. | Apr 2003 | B2 |
6558321 | Burd et al. | May 2003 | B1 |
6612985 | Eiffert et al. | Sep 2003 | B2 |
6641533 | Causey, III et al. | Nov 2003 | B2 |
6723045 | Cosentino et al. | Apr 2004 | B2 |
6755783 | Cosentino et al. | Jun 2004 | B2 |
6757898 | Ilsen et al. | Jun 2004 | B1 |
6770487 | Crosby | Aug 2004 | B2 |
6780645 | Hayter et al. | Aug 2004 | B2 |
6814844 | Bhullar et al. | Nov 2004 | B2 |
6849045 | Iliff | Feb 2005 | B2 |
6849237 | Housefield et al. | Feb 2005 | B2 |
6891936 | Kai et al. | May 2005 | B2 |
6968375 | Brown | Nov 2005 | B1 |
7004928 | Aceti et al. | Feb 2006 | B2 |
7056289 | Kasper et al. | Jun 2006 | B2 |
7127290 | Girouard et al. | Oct 2006 | B2 |
7215991 | Besson et al. | May 2007 | B2 |
7223236 | Brown | May 2007 | B2 |
7252636 | Brown | Aug 2007 | B2 |
7299081 | Mace et al. | Nov 2007 | B2 |
7319962 | Goedeke et al. | Jan 2008 | B2 |
7401413 | Nelson | Jul 2008 | B1 |
7433853 | Brockway et al. | Oct 2008 | B2 |
7478434 | Hinton et al. | Jan 2009 | B1 |
7577475 | Cosentino et al. | Aug 2009 | B2 |
7624028 | Brown | Nov 2009 | B1 |
7647234 | Ruderman et al. | Jan 2010 | B1 |
7733224 | Tran | Jun 2010 | B2 |
7736318 | Cosentino et al. | Jun 2010 | B2 |
7827040 | Brown | Nov 2010 | B2 |
7941327 | Brown | May 2011 | B2 |
7945451 | Cosentino et al. | May 2011 | B2 |
7972266 | Gobeyn et al. | Jul 2011 | B2 |
8015025 | Brown | Sep 2011 | B2 |
8034294 | Goldberg | Oct 2011 | B1 |
8140663 | Brown | Mar 2012 | B2 |
8419650 | Cosentino et al. | Apr 2013 | B2 |
8438038 | Cosentino et al. | May 2013 | B2 |
8525643 | Green et al. | Sep 2013 | B2 |
8532775 | Berg et al. | Sep 2013 | B2 |
20010020229 | Lash | Sep 2001 | A1 |
20010029322 | Iliff | Oct 2001 | A1 |
20010032099 | Joao | Oct 2001 | A1 |
20010048529 | Fotland | Dec 2001 | A1 |
20010053875 | Iliff | Dec 2001 | A1 |
20010056229 | Cosentino et al. | Dec 2001 | A1 |
20020010597 | Mayer et al. | Jan 2002 | A1 |
20020018478 | Takeyama et al. | Feb 2002 | A1 |
20020019747 | Ware et al. | Feb 2002 | A1 |
20020022973 | Sun et al. | Feb 2002 | A1 |
20020082480 | Riff et al. | Jun 2002 | A1 |
20020082665 | Haller et al. | Jun 2002 | A1 |
20020111539 | Cosentino et al. | Aug 2002 | A1 |
20020133502 | Rosenthal et al. | Sep 2002 | A1 |
20020147423 | Burbank et al. | Oct 2002 | A1 |
20020156650 | Klein et al. | Oct 2002 | A1 |
20020158775 | Wallace | Oct 2002 | A1 |
20020173991 | Avitall | Nov 2002 | A1 |
20030001742 | Eshelman et al. | Jan 2003 | A1 |
20030004758 | Luttrell | Jan 2003 | A1 |
20030028399 | Davis et al. | Feb 2003 | A1 |
20030050054 | Siu | Mar 2003 | A1 |
20030069753 | Brown | Apr 2003 | A1 |
20030083556 | Cosentino et al. | May 2003 | A1 |
20030229517 | Meserol et al. | Dec 2003 | A1 |
20040015191 | Otman et al. | Jan 2004 | A1 |
20040034286 | Kasper et al. | Feb 2004 | A1 |
20040078220 | Jackson | Apr 2004 | A1 |
20040117204 | Mazar et al. | Jun 2004 | A1 |
20040122297 | Stahmann et al. | Jun 2004 | A1 |
20040139048 | Kerr, II et al. | Jul 2004 | A1 |
20040147969 | Mann et al. | Jul 2004 | A1 |
20040147982 | Bardy | Jul 2004 | A1 |
20040172080 | Stadler et al. | Sep 2004 | A1 |
20040199409 | Brown | Oct 2004 | A1 |
20040220832 | Moll et al. | Nov 2004 | A1 |
20040225533 | Cosentino et al. | Nov 2004 | A1 |
20040236187 | Bock et al. | Nov 2004 | A1 |
20040260666 | Pestotnik et al. | Dec 2004 | A1 |
20050015115 | Sullivan et al. | Jan 2005 | A1 |
20050033127 | Ciurczak et al. | Feb 2005 | A1 |
20050038332 | Saidara et al. | Feb 2005 | A1 |
20050065813 | Mishelevich et al. | Mar 2005 | A1 |
20050075116 | Laird et al. | Apr 2005 | A1 |
20050172021 | Brown | Aug 2005 | A1 |
20050192487 | Cosentino et al. | Sep 2005 | A1 |
20050231375 | Kingston | Oct 2005 | A1 |
20050279631 | Celentano | Dec 2005 | A1 |
20060015017 | Cosentino et al. | Jan 2006 | A1 |
20060030890 | Cosentino et al. | Feb 2006 | A1 |
20060064030 | Cosentino et al. | Mar 2006 | A1 |
20060106290 | Bulat | May 2006 | A1 |
20060161457 | Rapaport et al. | Jul 2006 | A1 |
20060247985 | Liamos et al. | Nov 2006 | A1 |
20060248398 | Neel et al. | Nov 2006 | A1 |
20060271445 | Lee et al. | Nov 2006 | A1 |
20070011465 | Webber et al. | Jan 2007 | A1 |
20070021979 | Cosentino et al. | Jan 2007 | A1 |
20070073590 | Cosentino et al. | Mar 2007 | A1 |
20070118422 | Berger et al. | May 2007 | A1 |
20070155588 | Stark et al. | Jul 2007 | A1 |
20070231209 | Cosentino et al. | Oct 2007 | A1 |
20070231846 | Cosentino et al. | Oct 2007 | A1 |
20080117060 | Cuddihy et al. | May 2008 | A1 |
20080262871 | Lee et al. | Oct 2008 | A1 |
20080294024 | Cosentino et al. | Nov 2008 | A1 |
20090037216 | Bluemler et al. | Feb 2009 | A1 |
20090138207 | Cosentino et al. | May 2009 | A1 |
20090138717 | Calamera et al. | May 2009 | A1 |
20090192362 | Sweeney | Jul 2009 | A1 |
20090204028 | Richards | Aug 2009 | A1 |
20090216558 | Reisman et al. | Aug 2009 | A1 |
20090234916 | Cosentino et al. | Sep 2009 | A1 |
20100005416 | Hedmann et al. | Jan 2010 | A1 |
20100113891 | Barrett et al. | May 2010 | A1 |
20100121201 | Papaioannou | May 2010 | A1 |
20100137693 | Porras et al. | Jun 2010 | A1 |
20100249536 | Cosentino et al. | Sep 2010 | A1 |
20100295684 | Hsieh et al. | Nov 2010 | A1 |
20110098539 | Estocado | Apr 2011 | A1 |
20110105979 | Schlaeper et al. | May 2011 | A1 |
20110125532 | Cosentino et al. | May 2011 | A1 |
20110307284 | Thompson et al. | Dec 2011 | A1 |
20120041771 | Cosentino et al. | Feb 2012 | A1 |
20120041775 | Cosentino et al. | Feb 2012 | A1 |
20120323796 | Udani | Dec 2012 | A1 |
20130043997 | Cosentino et al. | Feb 2013 | A1 |
20130082837 | Cosentino et al. | Apr 2013 | A1 |
20130131574 | Cosentino et al. | May 2013 | A1 |
20130267795 | Cosentino et al. | Oct 2013 | A1 |
20130297344 | Cosentino et al. | Nov 2013 | A1 |
20130332730 | Cosentino et al. | Dec 2013 | A1 |
20140006054 | Cosentino et al. | Jan 2014 | A1 |
Number | Date | Country |
---|---|---|
43 35 869 | Oct 1994 | DE |
0 251 520 | Jan 1988 | EP |
0 256 806 | Feb 1988 | EP |
0 290 610 | Nov 1988 | EP |
0 505 627 | Sep 1992 | EP |
0 890 919 | Jan 1999 | EP |
0 896 828 | Feb 1999 | EP |
1 147 739 | Oct 2001 | EP |
0 880 407 | Apr 2002 | EP |
1 416 417 | May 2004 | EP |
1 547 516 | Jun 2005 | EP |
01006865 | Jan 1989 | JP |
09173304 | Jul 1997 | JP |
WO 9424929 | Nov 1994 | WO |
WO 9613707 | May 1996 | WO |
WO 9729847 | Aug 1997 | WO |
WO 9818211 | Apr 1998 | WO |
WO 9838909 | Sep 1998 | WO |
WO 9840835 | Sep 1998 | WO |
WO 9850873 | Nov 1998 | WO |
WO 9858338 | Dec 1998 | WO |
WO 9904043 | Jan 1999 | WO |
WO 9922236 | May 1999 | WO |
WO 9925110 | May 1999 | WO |
WO 0033072 | Jun 2000 | WO |
WO 0041613 | Jul 2000 | WO |
WO 0062662 | Oct 2000 | WO |
WO 0100086 | Jan 2001 | WO |
WO 0121065 | Mar 2001 | WO |
WO 0122343 | Mar 2001 | WO |
WO 0139089 | May 2001 | WO |
WO 0169513 | Sep 2001 | WO |
WO 0174229 | Oct 2001 | WO |
WO 0189363 | Nov 2001 | WO |
WO 03005891 | Jan 2003 | WO |
WO 03075756 | Sep 2003 | WO |
WO 2004106885 | Dec 2004 | WO |
WO 2004113911 | Dec 2004 | WO |
WO 2005040793 | May 2005 | WO |
WO 2007044877 | Apr 2007 | WO |
WO 2012021240 | Feb 2012 | WO |
Entry |
---|
Patel, U. et al., “A Computer-Based, Automated, Telephonic System to Monitor Patient Progress in the Home Setting”, Journal of Medical Systems, vol. 16, Nos. 2/3, pp. 101-112 (1992). |
“Technology to Help Meet Standards and Reduce Costs”, Alere Medical Incorporated, 6 pages (1998). |
“Telemedicine, Your Partner in Telemedicine”, Aerotel Medical Systems, Ltd., Internet at http://www.aerotel.com/telemed/under.html, last updated Sep. 5, 1998. |
“Telemedicine NEW: BP-TEL™ Transtelephonic Blood Pressure: Your Partner in Telemedicine”, http://www.aerotel.corn/telemed/, 2 pgs. (Feb. 6, 2001) last updated. |
Yazolino, L., “Effective, Daily At-home Monitoring of Chronically Ill Patients,” Medical Electronics, 4 pages (Sep. 1998). |
International Search Report for International Application No. PCT/US 03/07099, 8 pp., Jul. 22, 2003. |
“Thin-Link: Like Having a Personal Coach and Dietitian in Your Home Every Day,” http://web.archive.org/web/20041009141519/www.thin-link.com/program—weightloss.html, 2 pages (Date Printed Aug. 31, 2005). |
Teixeira, P. et al., “Weight Loss Readiness in Middle-Aged Women: Psychosocial Predictors of Success for Behavioral Weight Reduction,” Journal of Behavioral Medicine, vol. 25, No. 6, pp. 499-523 (Dec. 2002). |
Lüthje, L. et al., “Detection of heart failure decomposition using intrathoracic impedance monitoring by a triple-chamber implantable defibrillator,” Heart Rhythm, vol. 2, No. 9, pp. 997-999 (Sep. 2005). |
Bittorf et al., “Teaching Resources for Dermatology on the WWW—Quiz System and Dynamic Lecture Scripts using a HTTP-Database Demon,” Proc AMIA Annu Fall Symp., pp. 46-50 (1996). |
Request for Ex Parte Reexamination Filed Nov. 9, 2007, 25 pages. |
Request for Inter Parties Reexamination Filed Aug. 1, 2008, 126 pages. |
Action Closing Prosecution for U.S. Appl. No. 90/010,053 and U.S. Appl. No. 95/000,386, dated Jan. 17, 2012, 57 pages. |
Excerpts from File History of U.S. Patent No. 6,968,375, filed Sep. 8, 2000, Stephen J. Brown (339 pages). |
Excerpts from File History of U.S. Patent No. 7,252,636, filed Jun. 13, 2005, Stephen J. Brown (336 pages). |
Excerpts from File History of U.S. Patent No. 8,015,025, filed Nov. 15, 2006, Stephen J. Brown (271 pages). |
Excerpts from File History of U.S. Patent No. 8,140,663, filed Jun. 13, 2005, 505 pages. |
File History of Reexam U.S. Appl. No. 90/009,281, Filed Sep. 23, 2008, Stephn J. Brown, 646 pages. |
File History of U.S. Patent No. 6,368,273, filed Apr. 28, 1999, Stephen J. Brown, 407 pages. |
U.S. Appl. No. 90/009,281, Notice of Intent to issue a Reexamination Certificate, dated Mar. 16, 2010, 7 pages. |
EPO Communication pursuant to Rules 161(1) and 162 EPC for Application No. 09764994.1, dated Jul. 22, 2011. |
First Communication from European Patent Application No. 08767827.2 dated Sep. 28, 2011. |
European Search Report for Application No. 02768819.1, 3 pages, mailed Feb. 23, 2005. |
European Search Report for Application No. 10151955.1, 5 pages, mailed Aug. 10, 2010. |
European Search Report for Application No. 10166822.6, 5 pages, mailed Sep. 14, 2010. |
European Search Report for Application No. 10181162.8, 7 pages, mailed Jan. 12, 2011. |
European Search Report for Application No. 08767827.2 (PCT/US2008/006453), 7 pages, mailed Mar. 21, 2011. |
European Search Report for Application No. 10181851.6, 4 pages, mailed Jul. 22, 2011. |
European Search Report for Application No. 10181855.7, 5 pages, mailed Jul. 22, 2011. |
European Search Report for Application No. 11168162.3, 6 pages, mailed Jul. 28, 2011. |
European Search Report for Application No. 11167368.7, 7 pages, mailed Sep. 29, 2011. |
European Search Report for Application No. 11167369.5, 9 pages, mailed Oct. 6, 2011. |
Groner et al., “An Introduction to the CLINFO Prototype Data Management and Analysis System”, R-1541-NIH, 69 pages (Dec. 1977). |
Hughes, S., “Bedside Terminals: Clinicom,” Clinical Computing, vol. 5, No. 1 pp. 3 and 22-28 (1988). |
International Preliminary Report on Patentability for PCT/US2010/030497, 8 pages, mailed Aug. 25, 2011. |
International Search Report for International Application No. PCT/US00/24425, 8 pages, mailed Jan. 2, 2002. |
International Search Report for International Application No. PCT/US02/28465, 6 pages, mailed Dec. 10, 2002. |
International Search Report and Written Opinion for International Application No. PCT/US2004/041122, 13 pages, mailed Sep. 15, 2005. |
International Search Report and Written Opinion for International Application No. PCT/US2005/005739, 13 pages, mailed Oct. 24, 2005. |
International Search Report and Written Opinion for International Application No. PCT/US2006/036407, 12 pages, mailed Jan. 23, 2007. |
International Search Report and Written Opinion for International Application No. PCT/US2007/008223, 14 pages, mailed Aug. 23, 2007. |
International Search Report and Written Opinion for International Application No. PCT/US2007/002556, 17 pages, mailed May 28, 2008. |
International Search Report and Written Opinion for International Application No. PCT/US2007/008250, 16 pages, mailed Jun. 23, 2008. |
International Search Report and Written Opinion for International Application No. PCT/US08/06453, 12 pages, mailed Sep. 29, 2008. |
International Search Report and Written Opinion for International Application No. PCT/US2009/067090, 14 pages, mailed Feb. 12, 2010. |
International Search Report and Written Opinion for International Application No. PCT/US2010/030497, 16 pages, mailed Jul. 27, 2010. |
International Search Report and Written Opinion for International Application No. PCT/US2011/043643, 8 pages, mailed Sep. 23, 2011. |
International Search Report and Written Opinion for International Application No. PCT/US2012/037571, 12 pages, mailed Aug. 31, 2012. |
International Search Report and Written Opinion for International Application No. PCT/US2012/057896, 11 pages, mailed Feb. 13, 2013. |
International Search Report and Written Opinion for International Application No. PCT/US2012/038386 mailed Jul. 11, 2013. |
International Search Report and Written Opinion for International Application No. PCT/US2013/044954 mailed Sep. 20, 2013. |
International Search Report and Written Opinion for International Application No. PCT/US13/46375 mailed Jan. 10, 2014. |
Invitation to Pay Additional Fees with Partial International Search for International Application No. PCT/US2006/027440 , 8 pages, mailed Mar. 8, 2007. |
Invitation to Pay Additional Fees with Partial International Search for International Application No. PCT/US2007/002556 , 8 pages, mailed Apr. 3, 2008. |
Invitation to Pay Additional Fees with Partial International Search for International Application No. PCT/US2007/008250, 9 pages, mailed Apr. 16, 2008. |
Invitation to Pay Additional Fees with Partial International Search for International Application No. PCT/US2013/035271, 6 pages, mailed Nov. 4, 2013. |
Lobach, D., “Electronically Distributed, Computer-Generated, Individualized Feedback Enhances the Use of a Computerized Practice Guideline,” Proc. Annu. Symp. Comput. Appl. Med. Care, pp. 493-497 (1996). |
Lobach, D. et al., “Computerized Decision Support Based on a Clinical Practice Guideline Improves Compliance with Care Standards,” The American Journal of Medicine, vol. 102, pp. 89-98 (Jan. 1997). |
Lobach, D. et al., “Development and Evaluation of a Computer-Assisted Management Protocol (CAMP): Improved Compliance with Care Guidelines for Diabetes Mellitus,” Proc. Annu. Symp. Comput. Appl. Med. Care, pp. 787-791 (1994). |
Nilasena, D. et al., “A Computer-Generated Reminder System Improves Physician Cmopliance with Diabetes Preventive Care Guidelines,” Proc. Annu. Symp. Comput. Appl. Med. Care, pp. 640-645 (1995). |
Schrezenmeier, J. et al., “Computer Assisted Insulin Dosage Adjustment — Perspectives for Diabetes Control,” Hormone and Metabolic Research, Supplemental Series, vol. 24, pp. 116-123 (1990). |
Vincent et al., “The Effects of a Computer-Assisted Reminder System on Patient Compliance With Recommended Health Maintenance Procedures”, Proc. Annu. Symp. Comput. Appl. Med. Care, pp. 656-660 (1995). |
Webster's Ninth New Collegiate Dictionary Definition of “Computer”, 4 pages (1990). |
Number | Date | Country | |
---|---|---|---|
20040102685 A1 | May 2004 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09293619 | Apr 1999 | US |
Child | 09918247 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09918247 | Jul 2001 | US |
Child | 10719408 | US |